Spermosens AB (publ)
Research Spermosens AB (publ) (9R5) on Bullrun: market cap EUR 634.60K. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker9R5
- ExchangeF
- CountrySweden
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyEUR
- Market capEUR 634.60K
- Financial periodQ4 2025
- Net income-EUR 2.11M
- Free cash flow-EUR 2.21M
Valuation Snapshot
latest market cap is EUR 634.60K.
About Spermosens AB (publ)
Spermosens AB (publ) provides diagnostic health care products and services in Sweden. The company offers devices for male infertility for fertility diagnostics and treatments for the IVF market. It develops JUNO-Checked, that measures the binding between sperm and egg cell to enable individualized choice of fertility treatment based on measured binding. Spermosens AB (publ) was incorporated in 2018 and is headquartered in Lund, Sweden.
Frequently asked questions
What is Spermosens AB (publ)'s market cap?
Spermosens AB (publ)'s market capitalization is EUR 634.60K.
What does Spermosens AB (publ) do?
Spermosens AB (publ) provides diagnostic health care products and services in Sweden. The company offers devices for male infertility for fertility diagnostics and treatments for the IVF market.